Lucy Shapiro, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 80,000 shares at $21.14 ($1.7M) on 2014-03-21, disclosed to the SEC on 2014-03-25.
Open-market sale of $1.7M ANAC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANAC | SELL | 2013-04-19 | $200K | — | Filing → |
| ANAC | SELL | 2013-03-22 | $138K | — | Filing → |
| ANAC | SELL | 2012-10-05 | $200K | — | Filing → |